Also known as آسٹیوپوروسس مینجمنٹ
Diabetologist
M.B.B.S., Diploma in Diabetology
Diabetologist
M.B.B.S, MRCP (UK), MRCP (London), Specialty Certificate in Endocrinology and Diabetes
Diabetologist
M.B.B.S, MRCP (UK), MRCP (London), Specialty Certificate in Endocrinology and Diabetes
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Consultant Physician
MBBS, MCPS, M.D. (I.M), F.R.C.P. (London), F.R.C.P. (Edin.), F.C.C.P. (USA), Doctorate of Medicine in Gastroenterology
Consultant Physician
MBBS, MCPS, M.D. (I.M), F.R.C.P. (London), F.R.C.P. (Edin.), F.C.C.P. (USA), Doctorate of Medicine in Gastroenterology
Internal Medicine Specialist
MBBS, MD (Internal Medicine)
Diabetologist
M.B.B.S., DIP DAB
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Diabetologist
M.B.B.S, M.C.P.S, Certification in Family Medicine, Master Trainer Family Medicine, MRCGP International UK
Diabetologist
M.B.B.S, M.C.P.S, Certification in Family Medicine, Master Trainer Family Medicine, MRCGP International UK
Consultant Physician
MBBS, MCPS, FCPS
Internal Medicine Specialist
MBBS, PLAB (UK), FCPS (Gastroenterology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures